Health Patients Drive Treatment Choices in HER2-Mutated Lung Cancer Recent advancements in the treatment of HER2-mutated non-small cell lung cancer (NSCLC) underscore the importance of incorporating patient preferences into treatment decisions. With the... Editorial4 hours ago